1. Monitoring of intracerebellarly-administered natural killer cells with fluorine-19 MRI

   • Bridget A. Kennis
   • Keith A. Michel
   • Vidya Gopalakrishnan

   Laboratory Investigation 20 February 2019 Pages: 395 - 407

   

2. Correction to: Monitoring of intracerebellarly-administered natural killer cells with fluorine-19 MRI

   • Bridget A. Kennis
   • Keith A. Michel
   • Vidya Gopalakrishnan

   Correction 09 April 2019 Pages: 409 - 409

3. Modulating native GABA_A receptors in medulloblastoma with positive allosteric benzodiazepine-derivatives induces cell death

   • Laura Kallay
   • Havva Keskin
   • Soma Sengupta

   Laboratory Investigation Open access 06 February 2019 Pages: 411 - 422

   

4. SPINT2 is hypermethylated in both IDH1 mutated and wild-type glioblastomas, and exerts tumor suppression via reduction of c-Met activation

   • Fei Liu
   • Christopher D. Cox
   • Albert Lai

   Laboratory Investigation 05 March 2019 Pages: 423 - 434

   

5. Telomere elongation via alternative lengthening of telomeres (ALT) and telomerase activation in primary metastatic medulloblastoma of childhood

   • Simone Minasi
   • Caterina Baldi
   • Francesca Romana Buttarelli

   Laboratory Investigation 04 March 2019 Pages: 435 - 444

   

6. Targeted next-generation sequencing panel (TruSight Tumor 170) in diffuse glioma: a single institutional experience of 135 cases

   • Kiyong Na
   • Hyun-Soo Kim
   • Se Hoon Kim

   Clinical Study 01 February 2019 Pages: 445 - 454

   

7. Multicenter, single arm, phase II trial on the efficacy of ortataxel in recurrent glioblastoma

   • Antonio Silvani
   • Irene De Simone
   • the Italian Association of Neuro-Oncology

   Clinical Study 06 February 2019 Pages: 455 - 462

   

8. Withdrawal of antiepileptic drugs in patients with low grade and anaplastic glioma after long-term seizure freedom: a prospective observational study

   • M. Kerkhof
   • J. A. F. Koekkoek
   • M. J. B. Taphoorn

   Clinical Study Open access 18 February 2019 Pages: 463 - 470

   

9. Gamma Knife Stereotactic Radiosurgery favorably changes the clinical course of hemangioblastoma growth in von Hippel-Lindau and sporadic patients

   • Brittany Liebenow
   • Abigail Tatter
   • Stephen B. Tatter

   Clinical Study 07 February 2019 Pages: 471 - 478

   

10. Longer genotypically-estimated leukocyte telomere length is associated with increased meningioma risk

    • Ivo S. Muskens
    • Helen M. Hansen
    • Elizabeth B. Claus

    Clinical Study 22 February 2019 Pages: 479 - 487

    

11. Impact on survival of early tumor growth between surgery and radiotherapy in patients with de novo glioblastoma

    • Amaury De Barros
    • Justine Attal
    • Franck-Emmanuel Roux

    Clinical Study 19 February 2019 Pages: 489 - 497

    

12. Predictors of survival in metastatic melanoma patients with leptomeningeal disease (LMD)

    • Sherise D. Ferguson
    • Shivani Bindal
    • Isabella C. Glitza

    Clinical Study 07 March 2019 Pages: 499 - 509

    

13. Neuro-radiological characteristics of adult diffuse grade II and III insular gliomas classified according to WHO 2016

    • Paloma Compes
    • Emeline Tabouret
    • Dominique Figarella-Branger

    Clinical Study 11 February 2019 Pages: 511 - 520

    

14. Correction to: Neuro-radiological characteristics of adult diffuse grade II and III insular gliomas classified according to WHO 2016

    • Paloma Compes
    • Emeline Tabouret
    • Dominique Figarella-Branger

    Correction 11 March 2019 Pages: 521 - 521

15. High-dose radiation therapy is needed for intracranial control and long-term survival in patients with non-seminomatous germ cell tumor brain metastases

    • Dana L. Casey
    • Kenneth L. Pitter
    • T. Jonathan Yang

    Clinical Study 15 February 2019 Pages: 523 - 528

    

16. Role of postoperative tumor volume in patients with MGMT-unmethylated glioblastoma

    • Arthur H. A. Sales
    • Stefanie Bette
    • Jens Gempt

    Clinical Study 21 February 2019 Pages: 529 - 536

    

17. A multicenter phase II study of temozolomide plus disulfiram and copper for recurrent temozolomide-resistant glioblastoma

    • Jiayi Huang
    • Rekha Chaudhary
    • Jian L. Campian

    Clinical Study 15 February 2019 Pages: 537 - 544

    

18. Trans-eyebrow supraorbital keyhole approach to tuberculum sellae meningiomas: a series of 30 cases with long-term visual outcomes and recurrence rates

    • Meiqin Cai
    • Bo Hou
    • Ying Guo

    Clinical Study 22 February 2019 Pages: 545 - 555

    

19. Proton therapy for skull-base chondrosarcoma, a single-institution outcomes study

    • Adam L. Holtzman
    • Ronny L. Rotondo
    • William M. Mendenhall

    Clinical Study 02 March 2019 Pages: 557 - 563

    

20. Cognitive rehabilitation for executive dysfunction in brain tumor patients: a pilot randomized controlled trial

    • Nadine M. Richard
    • Lori J. Bernstein
    • Kim Edelstein

    Clinical Study 07 March 2019 Pages: 565 - 575

    

21. Awake craniotomies for epileptic gliomas: intraoperative and postoperative seizure control and prognostic factors

    • Yu-Chi Wang
    • Cheng-Chi Lee
    • Pin-Yuan Chen

    Clinical Study 25 February 2019 Pages: 577 - 586

    

22. pH-weighted amine chemical exchange saturation transfer echoplanar imaging (CEST-EPI) as a potential early biomarker for bevacizumab failure in recurrent glioblastoma

    • Jingwen Yao
    • Caleb Hock Pang Tan
    • Benjamin M. Ellingson

    Clinical Study 26 February 2019 Pages: 587 - 595